AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024

Rhea-AI Summary

AngioDynamics, a medical technology company, will report its fiscal 2024 fourth-quarter and full-year financial results on July 16, 2024, before market open. The company focuses on restoring blood flow in the vascular system, expanding cancer treatments, and improving patient quality of life. A conference call to discuss the results will be held at 8:00 a.m. ET on the same day. Dial-in options are available for both domestic and international participants, and the call will be webcast on the AngioDynamics investor website. A replay will be accessible online and via phone until July 23, 2024.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the fourth quarter and fiscal year 2024 before the market open on Tuesday, July 16, 2024. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results.

To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international).

This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at investors.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A recording of the call will also be available, until Tuesday, July 23, 2024 at 11:59 PM ET. To hear this recording, dial 1-844-512-2921 (domestic) or +1-412-317-6671 (international) and enter the passcode 13747424.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240709446033/en/

Investors:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

When will AngioDynamics report its Q4 and full-year fiscal 2024 results?

AngioDynamics will report its Q4 and full-year fiscal 2024 results on July 16, 2024, before the market opens.

How can I participate in AngioDynamics' conference call for their fiscal 2024 results?

To participate, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) on July 16, 2024, at 8:00 a.m. ET.

Where can I access the webcast of AngioDynamics' fiscal 2024 financial results call?

The webcast can be accessed from the 'Investors' section of the AngioDynamics website.

When will the replay of AngioDynamics' fiscal 2024 results conference call be available?

The replay will be available approximately one hour after the call ends and can be accessed until July 23, 2024, at 11:59 PM ET.